HDT BIO received NIH contract to advance novel RNA/LIONル COVID-19 vaccine into clinical trials
On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…
 
			On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…
 
			On Sept. 1, 2020, Atossa Therapeutics announced a positive interim safety assessment from the first cohort of healthy…
 
			On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…
 
			On Aug. 31, 2020, Vir Biotechnology and GlaxoSmithKline announced that the first patient was dosed in a phase…
 
			On Aug. 31, 2020, Royal Philips announced that it had received notice from the U.S. Department of Health…
 
			On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
 
			On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…
 
			On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
 
			On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
 
			On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…
 
			On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…
 
			On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
 
			On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
 
			On Aug. 27, 2020, scientists at Scripps Research announced they were partnering with peers in the U.S. and…
 
			On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…
 
			On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…
 
			On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…
 
			On Aug. 26, 2020, the National Science Foundation (NSF) announced that it was establishing new artificial intelligence institutes…
 
			On Aug. 26, 2020, Abbott announced the FDA had issued Emergency Use Authorization (EUA) for its BinaxNOWル COVID-19…
 
			On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…
 
			On Aug. 26, 2020, Altimmune announced additional positive results from the preclinical studies of its single-dose intranasal COVID-19…
 
			On Aug. 26, 2020, Stereotaxis announced a pioneering publication in the prestigious Journal of the American College of…
 
			On Aug. 26, 2020, VBI Vaccines announced data from three preclinical mouse studies conducted to enable selection of…
 
			On Aug. 26, 2020, Heat Biologics announced publication of positive preclinical COVID-19 results in bioRxiv. The company reported…
 
			On Aug. 25, 2020, AstraZeneca announced that the first participants have been dosed in a Phase I trial…
 
			On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio…
 
			On Aug. 25, 2020, Intravacc announced that it had partnered with American, Buffalo, NY, based Therapyx, to further…
 
			On Aug. 25, 2020, Codex DNA announced critical advancements in its development of the Digital-to-Biological Converterル (DBC) platform….
 
			On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
 
			On Aug. 24, 2020,Trevena announced that Imperial College London (ICL) had initiated a proof-of-concept study for TRV027 in…